Lipoprotein(a) [Lp(a)]

Lipoprotein(a) (Lp(a)) is a biomarker that has garnered increasing attention due to its potential role in predicting longevity. Elevated levels of Lp(a) have been associated with a higher risk of developing cardiovascular diseases, which are known to impact overall life expectancy. Therefore, monitoring Lp(a) levels can provide valuable insights into an individual’s risk for age-related health issues and mortality. In the context of a comprehensive longevity assessment, the measurement and management of Lp(a) levels can be a critical component in identifying and addressing potential risk factors for decreased lifespan. Understanding the influence of Lp(a) on longevity can help guide personalized interventions to promote healthy aging and extend lifespan. As such, integrating the assessment of Lp(a) levels into longevity evaluations can aid in identifying individuals who may benefit from targeted interventions to mitigate the impact of elevated Lp(a) on their overall lifespan.